268 related articles for article (PubMed ID: 7461467)
1. Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid.
Maton PN; Murphy GM; Dowling RH
Gut; 1980 Dec; 21(12):1082-6. PubMed ID: 7461467
[TBL] [Abstract][Full Text] [Related]
2. Hepatic HMGCoA reductase in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acids.
Maton PN; Ellis HJ; Higgins MJ; Dowling RH
Eur J Clin Invest; 1980 Aug; 10(4):325-32. PubMed ID: 6775960
[TBL] [Abstract][Full Text] [Related]
3. Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid.
Carulli N; Ponz De Leon M; Zironi F; Pinetti A; Smerieri A; Iori R; Loria P
J Lipid Res; 1980 Jan; 21(1):35-43. PubMed ID: 7354253
[TBL] [Abstract][Full Text] [Related]
4. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
LaRusso NF; Thistle JL
Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
[TBL] [Abstract][Full Text] [Related]
5. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
Leiss O; von Bergmann K
Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels.
Angelin B; Ewerth S; Einarsson K
J Lipid Res; 1983 Apr; 24(4):461-8. PubMed ID: 6854153
[TBL] [Abstract][Full Text] [Related]
7. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
Abate N; Carubbi F; Bozzoli M; Bertolotti M; Farah I; Rosi A; Carulli N
Ital J Gastroenterol; 1994; 26(6):287-93. PubMed ID: 7949265
[TBL] [Abstract][Full Text] [Related]
8. Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.
Meredith TJ; Williams GV; Maton PN; Murphy GM; Saxton HM; Dowling RH
Gut; 1982 May; 23(5):382-9. PubMed ID: 7076015
[TBL] [Abstract][Full Text] [Related]
9. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
[TBL] [Abstract][Full Text] [Related]
10. Effect of obesity and weight reduction on biliary cholesterol saturation and the response to chenodeoxycholic acid.
Reuben A; Qureshi Y; Murphy GM; Dowling RH
Eur J Clin Invest; 1986 Apr; 16(2):133-42. PubMed ID: 3089808
[TBL] [Abstract][Full Text] [Related]
11. Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones.
Iser JH; Maton PN; Murphy GM; Dowling RH
Br Med J; 1978 Jun; 1(6126):1509-12. PubMed ID: 656777
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study.
Roda E; Bazzoli F; Labate AM; Mazzella G; Roda A; Sama C; Festi D; Aldini R; Taroni F; Barbara L
Hepatology; 1982; 2(6):804-10. PubMed ID: 7141392
[TBL] [Abstract][Full Text] [Related]
13. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
Iwamura K
Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
[TBL] [Abstract][Full Text] [Related]
14. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.
Podda M; Zuin M; Dioguardi ML; Festorazzi S; Dioguardi N
Hepatology; 1982; 2(3):334-9. PubMed ID: 7076116
[TBL] [Abstract][Full Text] [Related]
15. Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones.
Zuin M; Petroni ML; Grandinetti G; Crosignani A; Bertolini E; Battezzati PM; Podda M
Scand J Gastroenterol; 1991 Mar; 26(3):257-62. PubMed ID: 1853147
[TBL] [Abstract][Full Text] [Related]
16. Faecal bile acid loss and bile acid pool size during short-term treatment with ursodeoxycholic and chenodeoxycholic acid in patients with radiolucent gallstones.
Salvioli G; Salati R
Gut; 1979 Aug; 20(8):698-704. PubMed ID: 488763
[TBL] [Abstract][Full Text] [Related]
17. [Nucleation time and growth time in patients with cholesterol gallstone--factors affecting nucleation time and growth time and effect of UDCA and CDCA].
Nomura Y
Nihon Shokakibyo Gakkai Zasshi; 1989 May; 86(5):1103-13. PubMed ID: 2795947
[TBL] [Abstract][Full Text] [Related]
18. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.
Tint GS; Salen G; Shefer S
Gastroenterology; 1986 Oct; 91(4):1007-18. PubMed ID: 3527851
[TBL] [Abstract][Full Text] [Related]
19. Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible?
Iser JH; Murphy GM; Dowling RH
Gut; 1977 Jan; 18(1):7-15. PubMed ID: 838406
[TBL] [Abstract][Full Text] [Related]
20. [Dissolution of biliary calculi with CDCA and UDCA].
Sugata F
Nihon Rinsho; 1984 Jul; 42(7):1683-9. PubMed ID: 6387220
[No Abstract] [Full Text] [Related]
[Next] [New Search]
